<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The location and functional role of <z:chebi fb="11" ids="18295">histamine</z:chebi> H4 receptors (H4Rs) in the gastrointestinal tract (GI) is reviewed, with particular reference to their involvement in the regulation of gastric acid secretion, gastric mucosal defense, intestinal motility and secretion, visceral sensitivity, <z:mp ids='MP_0001845'>inflammation</z:mp>, immunity and <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>H4Rs have been detected in different cell types of the gut, including immune cells, paracrine cells, <z:chebi fb="32" ids="24621">endocrine</z:chebi> cells and neurons; moreover, H4R expression was reported in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> specimens </plain></SENT>
<SENT sid="2" pm="."><plain>Functional studies with selective H4R ligands demonstrated protective effects in several experimental models of gastric mucosal damage and <z:mp ids='MP_0001858'>intestinal inflammation</z:mp>, suggesting a potential therapeutic role of drugs targeting this new receptor subtype in GI disorders, such as allergic <z:hpo ids='HP_0002242'>enteropathy</z:hpo>, <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD), <z:e sem="disease" ids="C0022104" disease_type="Disease or Syndrome" abbrv="IBS">irritable bowel syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e>) and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>